Cargando…
Cancer Resistance to Immunotherapy: Molecular Mechanisms and Tackling Strategies
Cancer immunotherapy has fundamentally altered cancer treatment; however, its efficacy is limited to a subset of patients in most clinical settings. The immune system plays a key role in cancer progression from tumor initiation to the metastatic state. Throughout the treatment course, communications...
Autores principales: | Vu, Son Hai, Vetrivel, Preethi, Kim, Jongmin, Lee, Myeong-Sok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513751/ https://www.ncbi.nlm.nih.gov/pubmed/36142818 http://dx.doi.org/10.3390/ijms231810906 |
Ejemplares similares
-
Tackling Resistance to Cancer Immunotherapy: What Do We Know?
por: Gondhowiardjo, Soehartati A., et al.
Publicado: (2020) -
Antibody-Based Immunotherapies as a Tool for Tackling Multidrug-Resistant Bacterial Infections
por: Seixas, António M. M., et al.
Publicado: (2022) -
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
por: Lodewijk, Iris, et al.
Publicado: (2021) -
Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022) -
Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
por: Abdin, Shifaa M., et al.
Publicado: (2018)